Marianna Ribeiro Cabral

Marianna Ribeiro Cabral

Auto-generated profile, based on publicly available information

Marianna Ribeiro Cabral

Laboratory of Pulmonary Investigation, Carlos Chagas Biophysics Institute, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 August 2026 in Cytotherapy
Verified
Journal Article
Open access
JVJuliana Borges Vieira
Juliana Borges Vieira
MAMariana Alves Antunes Almeida
Mariana Alves Antunes Almeida
CSCarla Medeiros da Silva
Carla Medeiros da Silva
MCMarianna Ribeiro Cabral
Marianna Ribeiro Cabral
Renata Trabach SantosRenata Trabach Santos
Renata Trabach Santos
FCFernanda Ferreira Cruz
Fernanda Ferreira Cruz

23 February 2026 in Cytotherapy
Verified
Journal Article
Open access
JSJohnatas D. Silva
Johnatas D. Silva
Miquéias Lopes-PachecoMiquéias Lopes-Pacheco
Miquéias Lopes-Pacheco
LCLuiza R.P. de Carvalho
Luiza R.P. de Carvalho
SASoraia C. Abreu
Soraia C. Abreu
MSMayck M.A. da Silva
Mayck M.A. da Silva
PRPatricia Rocco
Patricia Rocco
Sepsis remains a leading cause of mortality worldwide and is driven by a dysregulated host response to infection. Mesenchymal stromal cells (MSCs) derived from white adipose tissue (WAT) have shown therapeutic potential in sepsis; however, the properties of brown adipose tissue (BAT)-derived MSCs remain poorly characterized, particularly in obesity, a condition known to alter MSC phenotype and function. We compared the therapeutic efficacy of MSCs isolated from brown versus white adipose depots of obese donors in a clinically relevant model of sepsis in obese rats. Obesity was induced in Wistar rats through a high-fat diet. MSCs were isolated from brown and white adipose tissue and characterized by plastic adherence, surface marker expression, and gene expression profiling. Sepsis was induced by cecal ligation and puncture (CLP). Twenty-four hours after CLP, animals received saline, WAT-MSCs, or BAT-MSCs (1 × 10⁶ cells). Primary outcomes were 48-h survival and bacterial burden. Secondary outcomes included blinded histological assessment and molecular analyses of lung, kidney, and liver injury, focusing on inflammatory cytokines, fibrotic signaling, and oxidative stress. Both MSC populations met established characterization criteria. BAT-MSCs exhibited higher baseline expression of anti-inflammatory and antioxidant genes. In obese septic rats, treatment with BAT-MSCs significantly improved 48-h survival compared with WAT-MSCs and reduced bacterial burden more effectively. Histological analyses demonstrated greater protection across organs, including reduced alveolar collapse, renal brush-border injury, and hepatic necrosis. Molecular analyses showed more pronounced suppression of interleukin-6, interleukin-1β, and transforming growth factor-β signaling, along with reduced collagen deposition and oxidative stress (all P < 0.05). In obese septic rats, BAT-MSCs provided superior early survival benefit and multi-organ protection compared with WAT-MSCs. These findings identify brown adipose tissue as a promising MSC source for sepsis therapy and support further translational and mechanistic investigation.